KR20240144894A - 거대고리 펩티드를 제조하는 공정 - Google Patents

거대고리 펩티드를 제조하는 공정 Download PDF

Info

Publication number
KR20240144894A
KR20240144894A KR1020247023022A KR20247023022A KR20240144894A KR 20240144894 A KR20240144894 A KR 20240144894A KR 1020247023022 A KR1020247023022 A KR 1020247023022A KR 20247023022 A KR20247023022 A KR 20247023022A KR 20240144894 A KR20240144894 A KR 20240144894A
Authority
KR
South Korea
Prior art keywords
compound
formula
fmoc
boc
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247023022A
Other languages
English (en)
Korean (ko)
Inventor
진-마이클 애덤
프리츠 브리쓰
파스칼 진 클라우드 도트
파비안 록산 호프만-에머리
울프 고에란 라르손
쿠르트 푸엔테너
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20240144894A publication Critical patent/KR20240144894A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020247023022A 2022-02-14 2023-02-13 거대고리 펩티드를 제조하는 공정 Pending KR20240144894A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22156480 2022-02-14
EP22156480.0 2022-02-14
PCT/EP2023/053409 WO2023152347A1 (en) 2022-02-14 2023-02-13 Process for manufacturing macrocyclic peptides

Publications (1)

Publication Number Publication Date
KR20240144894A true KR20240144894A (ko) 2024-10-04

Family

ID=80683163

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247023022A Pending KR20240144894A (ko) 2022-02-14 2023-02-13 거대고리 펩티드를 제조하는 공정

Country Status (12)

Country Link
US (1) US20250109166A1 (cg-RX-API-DMAC7.html)
EP (1) EP4479396A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505521A (cg-RX-API-DMAC7.html)
KR (1) KR20240144894A (cg-RX-API-DMAC7.html)
CN (1) CN118660878A (cg-RX-API-DMAC7.html)
AR (1) AR128501A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023217269A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237617A1 (cg-RX-API-DMAC7.html)
IL (1) IL313664A (cg-RX-API-DMAC7.html)
MX (1) MX2024009210A (cg-RX-API-DMAC7.html)
TW (1) TW202342493A (cg-RX-API-DMAC7.html)
WO (1) WO2023152347A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026068674A1 (en) 2024-09-27 2026-04-02 F. Hoffmann-La Roche Ag Process for deprotection of aminoacid derivatives
WO2026093183A1 (en) 2024-10-29 2026-05-07 F. Hoffmann-La Roche Ag Process for manufacturing an antibiotic macrocyclic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6136934B2 (ja) 2011-12-15 2017-05-31 味の素株式会社 Fmoc基の除去方法
US11819532B2 (en) * 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii

Also Published As

Publication number Publication date
AR128501A1 (es) 2024-05-15
WO2023152347A1 (en) 2023-08-17
US20250109166A1 (en) 2025-04-03
MX2024009210A (es) 2024-08-06
CN118660878A (zh) 2024-09-17
EP4479396A1 (en) 2024-12-25
JP2025505521A (ja) 2025-02-28
CA3237617A1 (en) 2023-08-17
TW202342493A (zh) 2023-11-01
IL313664A (en) 2024-08-01
AU2023217269A1 (en) 2024-05-16

Similar Documents

Publication Publication Date Title
KR101467598B1 (ko) Hcv 프로테아제 억제제 중간체의 제조방법
AU2011279602B2 (en) Process for preparing a biphenyl-2-ylcarbamic acid
US20250109166A1 (en) Process for manufacturing macrocyclic peptides
JP2010535784A (ja) C型肝炎の治療に有用な化合物の合成方法
US12240797B2 (en) Method of preparing a DON prodrug from L-glutamic acid
CA3214664A1 (en) Synthesis of rapamycin analog compounds
JP2026063085A (ja) トロフィネチドの組成物
CN107810189B (zh) 用于制备氮芥衍生物的方法
CN105408317A (zh) 用于生产Sovaprevir的方法
JP2002502378A (ja) グアニジル化試薬
WO2020262259A1 (ja) ペプチド化合物の製造方法、保護基形成用試薬、及び、縮合多環化合物
WO2015173779A1 (en) Process for the preparation of teneligliptin and its novel intermediates
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
WO2013131978A1 (en) Process for the preparation of intermediates useful in the preparation of a viral protease inhibitor
EP1660493B1 (en) Peptidyl heterocyclic ketone derivatives and preparation processes
TW202302620A (zh) 胺基酸或肽之製造方法、保護基形成用試藥及化合物
HK40111281A (en) Process for manufacturing macrocyclic peptides
WO2005007634A1 (en) 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation
JPWO2002048153A1 (ja) Gm−95物質の製法
AU770530B2 (en) Process for the production of N-protected azetidine-2-carboxylic acids (AzeOHs)
NZ523217A (en) Chemical process
KR100194158B1 (ko) 1-(d-3-아세틸티오-2-메틸프로파노일)-l-프롤린-l-페닐알라닌의 제조방법
CN104768930B (zh) 光学活性双环脲化合物的制造方法
EA049473B1 (ru) Композиции трофинетида
JP2002265481A (ja) 高分子担持光学活性ホスフィン化合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000